title: Erythropoietin and heart failure: the end of a promise?
authors.forename: Lennaert
authors.initials: L
authors.lastname: Kleijn
authors.forename: B Daan
authors.initials: BD
authors.lastname: Westenbrink
authors.forename: Peter
authors.initials: P
authors.lastname: van der Meer
mesh_terms: D000740:Anemia / Q000150:complications* / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D000068256:Darbepoetin alfa; D004921:Erythropoietin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006333:Heart Failure / Q000150:complications* / Q000401:mortality; D006397:Hematinics / Q000627:therapeutic use*; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D011788:Quality of Life; D016896:Treatment Outcome
chemical_list: D006397:Hematinics; D004921:Erythropoietin; D000068256:Darbepoetin alfa